Actively Recruiting
Evaluation of the Calyan Pacemaker Device for Ventricular Pacing in Adults with Bradycardia
Led by Calyan Technologies · Updated on 2026-09-01
10
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the Calyan pacemaker system in an early feasibility study to assess its initial clinical safety, device functionality, stability, and potential effectiveness for people who need ventricular pacing due to bradycardia. This study aims to gather data to support the design of a larger future trial and focuses on patients with specific pacemaker needs according to established guidelines. The study is sponsored by Calyan Technologies and involves adults aged 18 and above with suitable health conditions. Participants will have the Calyan pacemaker implanted under the chest below the xiphoid process using specialized delivery tools. The devices FlexArm electrodes contact the hearts pericardial surface to provide pacing, which is adjusted wirelessly via a tablet programmer using secure Bluetooth. If the device implantation meets acute success criteria, chronic pacing will be delivered over a primary follow-up period of 3 months, with extended monitoring continuing afterward to evaluate device performance and safety. During the study, participants will be monitored for procedure- and device-related serious adverse events and for successful chronic ventricular pacing. Researchers will collect data over the 3-month primary period and beyond to observe device stability and clinical outcomes. Participants will undergo assessments related to device function and safety, with follow-up continuing until the study completion. The total study duration extends up to the end of 2027, allowing long-term evaluation of the Calyan pacemaker system.
CONDITIONS
Brief Title
Chronic Evaluation of Novel Pacemaker System
Research Team
I
Imad Libbus, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here